DK3160500T3 - Clostridium difficile immunogen sammensætning - Google Patents

Clostridium difficile immunogen sammensætning Download PDF

Info

Publication number
DK3160500T3
DK3160500T3 DK15733404T DK15733404T DK3160500T3 DK 3160500 T3 DK3160500 T3 DK 3160500T3 DK 15733404 T DK15733404 T DK 15733404T DK 15733404 T DK15733404 T DK 15733404T DK 3160500 T3 DK3160500 T3 DK 3160500T3
Authority
DK
Denmark
Prior art keywords
immunogenic composition
clostridium difficile
difficile immunogenic
clostridium
composition
Prior art date
Application number
DK15733404T
Other languages
Danish (da)
English (en)
Inventor
Cindy Castado
Original Assignee
Glaxosmithkline Biologicals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1411306.2A external-priority patent/GB201411306D0/en
Priority claimed from GB201411371A external-priority patent/GB201411371D0/en
Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa
Application granted granted Critical
Publication of DK3160500T3 publication Critical patent/DK3160500T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK15733404T 2014-06-25 2015-06-25 Clostridium difficile immunogen sammensætning DK3160500T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1411306.2A GB201411306D0 (en) 2014-06-25 2014-06-25 Immunogenic composition
GB201411371A GB201411371D0 (en) 2014-06-26 2014-06-26 Immunogenic composition
PCT/EP2015/064324 WO2015197737A1 (en) 2014-06-25 2015-06-25 Clostridium difficile immunogenic composition

Publications (1)

Publication Number Publication Date
DK3160500T3 true DK3160500T3 (da) 2019-11-11

Family

ID=53498986

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15733404T DK3160500T3 (da) 2014-06-25 2015-06-25 Clostridium difficile immunogen sammensætning

Country Status (17)

Country Link
US (1) US20170218031A1 (cg-RX-API-DMAC7.html)
EP (2) EP3636278A3 (cg-RX-API-DMAC7.html)
JP (2) JP6688233B2 (cg-RX-API-DMAC7.html)
CN (1) CN106536544B (cg-RX-API-DMAC7.html)
BE (1) BE1022949B1 (cg-RX-API-DMAC7.html)
BR (1) BR112016030096B1 (cg-RX-API-DMAC7.html)
CY (1) CY1122145T1 (cg-RX-API-DMAC7.html)
DK (1) DK3160500T3 (cg-RX-API-DMAC7.html)
ES (1) ES2749701T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20191864T1 (cg-RX-API-DMAC7.html)
HU (1) HUE045936T2 (cg-RX-API-DMAC7.html)
LT (1) LT3160500T (cg-RX-API-DMAC7.html)
MX (1) MX374380B (cg-RX-API-DMAC7.html)
PL (1) PL3160500T3 (cg-RX-API-DMAC7.html)
PT (1) PT3160500T (cg-RX-API-DMAC7.html)
SI (1) SI3160500T1 (cg-RX-API-DMAC7.html)
WO (1) WO2015197737A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11123419B2 (en) * 2017-03-15 2021-09-21 Novavax, Inc. Methods and compositions for inducing immune responses against Clostridium difficile
WO2019243307A1 (en) 2018-06-19 2019-12-26 Glaxosmithkline Biologicals Sa Immunogenic composition
GB202205833D0 (en) 2022-04-21 2022-06-08 Glaxosmithkline Biologicals Sa Bacteriophage

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4235877A (en) 1979-06-27 1980-11-25 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
US4436727A (en) 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4866034A (en) 1982-05-26 1989-09-12 Ribi Immunochem Research Inc. Refined detoxified endotoxin
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US4877611A (en) 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
AU614755B2 (en) 1987-06-05 1991-09-12 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Autocrine motility factors in cancer diagnosis and management
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
ATE115862T1 (de) 1989-02-04 1995-01-15 Akzo Nobel Nv Tocole als impfstoffadjuvans.
SK279188B6 (sk) 1992-06-25 1998-07-08 Smithkline Beecham Biologicals S.A. Vakcínová kompozícia spôsob jej prípravy a použiti
ES2162139T5 (es) 1993-03-23 2008-05-16 Smithkline Beecham Biologicals S.A. Composiciones de vacuna que contienen monofosforil-lipido a 3-o-desacilado.
NZ337543A (en) 1994-10-24 2002-06-28 Allergan Inc Composition comprising avian antitoxin against clostridial neurotoxin protein and method for producing recombinant antitoxin proteins are provided for
UA56132C2 (uk) 1995-04-25 2003-05-15 Смітклайн Бічем Байолоджікалс С.А. Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини
CA2220530A1 (en) 1995-06-02 1996-12-05 Incyte Pharmaceuticals, Inc. Improved method for obtaining full-length cdna sequences
EP1169456B1 (en) 1999-04-09 2012-07-11 Intercell USA, Inc. Recombinant production of Clostridium difficile Toxin A or Toxin B
WO2001073030A2 (en) 2000-03-28 2001-10-04 Diadexus, Inc. Compositions and methods of diagnosing, monitoring, staging, imaging and treating colon cancer
AU2003304316A1 (en) * 2002-11-08 2005-01-28 President And Fellows Of Harvard College Compounds and methods for the treatment and prevention of bacterial infection
JP6084631B2 (ja) * 2011-12-08 2017-02-22 ノバルティス アーゲー Ｃｌｏｓｔｒｉｄｉｕｍｄｉｆｆｉｃｉｌｅ毒素ベースのワクチン
AR089797A1 (es) 2012-01-27 2014-09-17 Merck Sharp & Dohme Vacunas contra clostridum difficile que comprenden toxinas recombinantes
HRP20190711T1 (hr) * 2012-12-05 2019-05-31 Glaxosmithkline Biologicals S.A. Imunogeni pripravak
GB201223342D0 (en) * 2012-12-23 2013-02-06 Glaxosmithkline Biolog Sa Immunogenic composition

Also Published As

Publication number Publication date
BR112016030096A8 (pt) 2021-07-06
BR112016030096B1 (pt) 2023-10-03
JP2020100625A (ja) 2020-07-02
BE1022949A1 (fr) 2016-10-21
EP3160500A1 (en) 2017-05-03
WO2015197737A1 (en) 2015-12-30
BE1022949B1 (fr) 2016-10-21
JP6688233B2 (ja) 2020-04-28
LT3160500T (lt) 2019-10-25
PL3160500T3 (pl) 2020-02-28
HUE045936T2 (hu) 2020-01-28
HRP20191864T1 (hr) 2020-01-10
CN106536544A (zh) 2017-03-22
MX2016017094A (es) 2017-05-03
EP3636278A3 (en) 2020-07-15
EP3636278A2 (en) 2020-04-15
CN106536544B (zh) 2020-04-07
MX374380B (es) 2025-03-06
US20170218031A1 (en) 2017-08-03
BR112016030096A2 (pt) 2017-08-22
ES2749701T3 (es) 2020-03-23
CA2952118A1 (en) 2015-12-30
PT3160500T (pt) 2019-11-11
EP3160500B1 (en) 2019-08-21
JP2017520573A (ja) 2017-07-27
SI3160500T1 (sl) 2019-11-29
CY1122145T1 (el) 2020-11-25

Similar Documents

Publication Publication Date Title
DK3146065T3 (da) Methods and compositions for reducing clostridium difficile infection
DK3096741T3 (da) Fremgangsmåde til fremstillingen af hybridosomer
LT3536380T (lt) Greitai veikiančios insulino kompozicijos
DK3757214T3 (da) Sammensætninger til modulering af sod-1-ekspression
DK3040326T3 (da) Haloolefin-baseret sammensætning
DK3215173T3 (da) Glycopeptidsammensætninger
DK3233108T3 (da) Hurtigtvirkende insulinsammensætninger
DK3174858T3 (da) Fremgangsmåde til fremstilling af pyrazoler
FR3024363B1 (fr) Composition thermogelifiable
DK3325487T3 (da) Formulering til bløde, anticholinerge analoger
GB201610599D0 (en) Immunogenic Composition
DK3018192T3 (da) Biodegraderbar fedtsammensætning til aerogenerator
DK3129007T3 (da) Vaccinesammensætninger
CL2017000639A1 (es) Composición
DK3215127T3 (da) Sammensætninger omfattende cyclosporin
EP3397277C0 (en) IMMUNOGENIC COMPOSITION
HUE070090T2 (hu) Összetétel
GB201614485D0 (en) Immunogenic composition
DK3200827T3 (da) Sammensætninger
DK3160500T3 (da) Clostridium difficile immunogen sammensætning
DK3217964T3 (da) Sammensætning
FR3019552B1 (fr) Composition filmogene
GB201411371D0 (en) Immunogenic composition
GB201411306D0 (en) Immunogenic composition
GB201401883D0 (en) Combination immunogenic compositions